Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur Patel

Showing results (271-280 of 357) with videos related to

Pageof 36
Sort By:
American Journal of Hematology|April 23, 2021
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burdenMusa Yilmaz, Naval Daver, Gautam Borthakur, et al.
American Journal of Hematology|April 13, 2024
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implicationsTareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamanna, et al.
The American Journal of Surgical Pathology|June 19, 2013
Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 casesEric Y Loo, L Jeffrey Medeiros, Tariq N Aladily, et al.
Circulation. Cardiovascular Quality and Outcomes|September 15, 2017
Association Between Living in Food Deserts and Cardiovascular RiskHeval M Kelli, Muhammad Hammadah, Hina Ahmed, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome MappingEduardo Edelman Saul, Samuel Urrutia, Hui Yang, et al.
Cancer|October 15, 2016
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agentsElias Jabbour, Stefan Faderl, Koji Sasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2017
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral TherapyIra M Jacobson, Mary K Washington, Maria Buti, et al.
Haematologica|August 20, 2016
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemiaBetül Oran, Jeff L Jorgensen, David Marin, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVRAlexander J Thompson, Rosanna Santoro, Valeria Piazzolla, et al.
Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3David R Nelson, Yves Benhamou, Wan-Long Chuang, et al.
Pageof 36

Showing results (271-280 of 357) with videos related to

Sort By:
Pageof 36
American Journal of Hematology|April 23, 2021
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burdenMusa Yilmaz, Naval Daver, Gautam Borthakur, et al.
American Journal of Hematology|April 13, 2024
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implicationsTareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamanna, et al.
The American Journal of Surgical Pathology|June 19, 2013
Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 casesEric Y Loo, L Jeffrey Medeiros, Tariq N Aladily, et al.
Circulation. Cardiovascular Quality and Outcomes|September 15, 2017
Association Between Living in Food Deserts and Cardiovascular RiskHeval M Kelli, Muhammad Hammadah, Hina Ahmed, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome MappingEduardo Edelman Saul, Samuel Urrutia, Hui Yang, et al.
Cancer|October 15, 2016
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agentsElias Jabbour, Stefan Faderl, Koji Sasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2017
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral TherapyIra M Jacobson, Mary K Washington, Maria Buti, et al.
Haematologica|August 20, 2016
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemiaBetül Oran, Jeff L Jorgensen, David Marin, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVRAlexander J Thompson, Rosanna Santoro, Valeria Piazzolla, et al.
Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3David R Nelson, Yves Benhamou, Wan-Long Chuang, et al.
Pageof 36